基因2型和3型丙型肝炎患者能否减少利巴韦林的剂量?

{"title":"基因2型和3型丙型肝炎患者能否减少利巴韦林的剂量?","authors":"Ine-Mari Bornman, Z. Younossi","doi":"10.1097/EBG.0B013E31818D4120","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":151924,"journal":{"name":"Evidence-based Gastroenterology","volume":"5 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2008-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CAN THE DOSE OF RIBAVIRIN BE REDUCED FOR PATIENTS INFECTED WITH HEPATITIS C, GENOTYPES 2 AND 3?\",\"authors\":\"Ine-Mari Bornman, Z. Younossi\",\"doi\":\"10.1097/EBG.0B013E31818D4120\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":151924,\"journal\":{\"name\":\"Evidence-based Gastroenterology\",\"volume\":\"5 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evidence-based Gastroenterology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/EBG.0B013E31818D4120\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence-based Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/EBG.0B013E31818D4120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}